Tag: Nasdaq:FBIO

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT(cosibelimab-ipdl)

WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”)…

GlobeNews Wire GlobeNews Wire